JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

B6099 LY3023414

Target: Akt|PI3K|mTOR|DNA-PK

Summary: class I PI3K isoforms, mTOR and DNA-PK inhibitor

≥40.6 mg/mL
B6100 Valrocemide

Summary: anticonvulsant agent

insoluble in H2O; ≥20 mg/mL
B6101 Bohemine

Summary: CDK inhibitor

insoluble in H2O; ≥17 mg/mL
B6102 NS 11394

Summary: GABA(A) receptor-positive modulator

≥35.3 mg/mL
B6103 Casin

Summary: GTPase Cdc42 inhibitor

≥30.6 mg/mL
B6104 BVT 2733

Summary: 11beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor

≥42.9 mg/mL
B6105 Tizoxanide

Summary: anti-infective compound

≥26.5 mg/mL
B6106 Daprodustat(GSK1278863)

Summary: HIF-prolyl hydroxylase inhibitor

insoluble in EtOH; insoluble in H2O; ≥7.86 mg/mL
B6107 ML241

Summary: p97 ATPase inhibitor

Soluble in DMSO
B6108 IC261

Summary: CK1 inhibitor

≥31.1 mg/mL